GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SynAct Pharma SYNACT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

15.28

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

SynAct Pharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
Operating income−SEK 117.2m−SEK 90.0m−SEK 224.5m−SEK 106.8m−SEK 76.7m
Net income−SEK 110.8m−SEK 82.4m−SEK 215.8m−SEK 99.2m−SEK 69.3m
Free cash flow−SEK 97.3m−SEK 89.2m−SEK 100.2m−SEK 117.6m−SEK 65.0m
Total assetsSEK 220.5mSEK 270.5mSEK 228.0mSEK 142.6mSEK 38.4m
Shareholders' equitySEK 170.3mSEK 214.2mSEK 176.2mSEK 126.5mSEK 20.9m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.